25 XP   0   0   10

Beijing SL Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Beijing SL Pharmaceutical Co Ltd together

PenkeI guess you are interested in Beijing SL Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Beijing SL Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Beijing SL Pharmaceutical Co Ltd

I send you an email if I find something interesting about Beijing SL Pharmaceutical Co Ltd.

Quick analysis of Beijing SL Pharmaceutical Co Ltd (30 sec.)










What can you expect buying and holding a share of Beijing SL Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.06
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥5.33
Expected worth in 1 year
¥5.93
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥1.00
Return On Investment
11.9%

For what price can you sell your share?

Current Price per Share
¥8.38
Expected price per share
¥7.05 - ¥9.73
How sure are you?
50%

1. Valuation of Beijing SL Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥8.38

Intrinsic Value Per Share

¥-0.53 - ¥2.80

Total Value Per Share

¥4.80 - ¥8.13

2. Growth of Beijing SL Pharmaceutical Co Ltd (5 min.)




Is Beijing SL Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$757.2m$736m$21.1m2.8%

How much money is Beijing SL Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$32.3m$58.8m-$26.4m-81.7%
Net Profit Margin22.3%35.1%--

How much money comes from the company's main activities?

3. Financial Health of Beijing SL Pharmaceutical Co Ltd (5 min.)




What can you expect buying and holding a share of Beijing SL Pharmaceutical Co Ltd? (5 min.)

Welcome investor! Beijing SL Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of Beijing SL Pharmaceutical Co Ltd.

What can you expect buying and holding a share of Beijing SL Pharmaceutical Co Ltd?

First you should know what it really means to hold a share of Beijing SL Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Beijing SL Pharmaceutical Co Ltd is ¥8.38. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Beijing SL Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Beijing SL Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥5.33. Based on the TTM, the Book Value Change Per Share is ¥0.15 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.33 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.10 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Beijing SL Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.030.4%0.030.4%0.060.7%0.060.7%0.070.8%
Usd Book Value Change Per Share0.020.2%0.020.2%0.050.5%0.030.4%0.050.5%
Usd Dividend Per Share0.010.2%0.010.2%0.010.2%0.030.3%0.020.2%
Usd Total Gains Per Share0.030.4%0.030.4%0.060.7%0.060.7%0.070.8%
Usd Price Per Share1.14-1.14-1.49-1.85-3.43-
Price to Earnings Ratio36.03-36.03-26.07-32.58-49.16-
Price-to-Total Gains Ratio33.02-33.02-24.99-31.61-49.21-
Price to Book Ratio1.54-1.54-2.09-2.83-7.09-
Price-to-Total Gains Ratio33.02-33.02-24.99-31.61-49.21-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.158116
Number of shares863
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.03
Usd Book Value Change Per Share0.020.03
Usd Total Gains Per Share0.030.06
Gains per Quarter (863 shares)29.6949.67
Gains per Year (863 shares)118.76198.69
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1487110989110189
295142228178219388
3143213347267329587
4191284466356438786
5239355585446548985
62864267045356571184
73344978236247671383
83825689427138771582
942963910618029861781
10477711118089110961980

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%22.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%22.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%19.00.03.086.4%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%22.00.00.0100.0%

Fundamentals of Beijing SL Pharmaceutical Co Ltd

About Beijing SL Pharmaceutical Co Ltd

Beijing SL Pharmaceutical Co., Ltd., a biopharmaceutical company, research, develops, produces, and markets genetic engineering and related drugs in the People's Republic of China and internationally. The company's finished formulations includes temozolomide; arsenic trioxide; lenalidomide capsules; docetaxel; paclitaxel; recombinant human granulocyte colony-stimulating factor; recombinant human interleukin-11; recombinant human interleukin-2; thymopentin; vinorelbine bitartrate; hydroxyl-camptothecine; nimustine hydrochloride; asparaginase; PEG L-asparaginase; calcium foliate; recombinant human basic fibroblast growth factor; liraglutide; insulin aspart 30; insulin aspart 50; insulin aspart; recombinant human follitropin(rh-fsh); ciclosporin; mycophenolate mofetil dispersible; voriconazole; ornidazole; adefovir dipivoxil; levofloxacin hydrochloride; azithromycin; ribavirin; tenofovir disoproxil fumarate; valacylovir hydrochloride; lysozyme; stavudine; tropisetron hydrochloride; granisetron hydrochloride; omeprazole; ademetionine 1,4-butanedisulfonate; glutathione; rivaroxaban; enoxaparin sodium; coenzyme complex; ginkgo biloba extract; simvastatin; telmisartan; naftopidil; nicergoline; zaleplon; cytidine disodium triphosphate; febuxostat; risedronate sodium; loratadine dispersible; somatostatin; octreotide acetate; calcitonin; paracetamol and tramadol hydrochloride; and etodolac. It also offers active pharmaceutical ingredients. The company was formerly known as Beijing BaiLuyuan Bio-Pharmaceutical Co., Ltd and changed its name to Beijing SL Pharmaceutical Co., Ltd. in 1998. Beijing SL Pharmaceutical Co., Ltd. was founded in 1994 and is headquartered in Beijing, the People's Republic of China.

Fundamental data was last updated by Penke on 2024-04-14 12:29:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is fair priced.

1.1. Profitability of Beijing SL Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Beijing SL Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Beijing SL Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 22.3% means that ¥0.22 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Beijing SL Pharmaceutical Co Ltd:

  • The MRQ is 22.3%. The company is making a huge profit. +2
  • The TTM is 22.3%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ22.3%TTM22.3%0.0%
TTM22.3%YOY35.1%-12.7%
TTM22.3%5Y28.1%-5.8%
5Y28.1%10Y38.5%-10.4%
1.1.2. Return on Assets

Shows how efficient Beijing SL Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Beijing SL Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 4.0% Return on Assets means that Beijing SL Pharmaceutical Co Ltd generated ¥0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Beijing SL Pharmaceutical Co Ltd:

  • The MRQ is 4.0%. Using its assets, the company is less efficient in making profit.
  • The TTM is 4.0%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ4.0%TTM4.0%0.0%
TTM4.0%YOY7.4%-3.4%
TTM4.0%5Y7.8%-3.8%
5Y7.8%10Y11.9%-4.1%
1.1.3. Return on Equity

Shows how efficient Beijing SL Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Beijing SL Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 4.3% Return on Equity means Beijing SL Pharmaceutical Co Ltd generated ¥0.04 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Beijing SL Pharmaceutical Co Ltd:

  • The MRQ is 4.3%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 4.3%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ4.3%TTM4.3%0.0%
TTM4.3%YOY8.0%-3.7%
TTM4.3%5Y8.5%-4.2%
5Y8.5%10Y12.7%-4.2%

1.2. Operating Efficiency of Beijing SL Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Beijing SL Pharmaceutical Co Ltd is operating .

  • Measures how much profit Beijing SL Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Beijing SL Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Beijing SL Pharmaceutical Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY17.5%-17.5%
TTM-5Y16.8%-16.8%
5Y16.8%10Y21.5%-4.7%
1.2.2. Operating Ratio

Measures how efficient Beijing SL Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.98 means that the operating costs are ¥0.98 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Beijing SL Pharmaceutical Co Ltd:

  • The MRQ is 0.976. The company is less efficient in keeping operating costs low.
  • The TTM is 0.976. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.976TTM0.9760.000
TTM0.976YOY0.941+0.035
TTM0.9765Y0.953+0.023
5Y0.95310Y0.808+0.146

1.3. Liquidity of Beijing SL Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Beijing SL Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 6.92 means the company has ¥6.92 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Beijing SL Pharmaceutical Co Ltd:

  • The MRQ is 6.916. The company is very able to pay all its short-term debts. +2
  • The TTM is 6.916. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.916TTM6.9160.000
TTM6.916YOY7.071-0.154
TTM6.9165Y7.204-0.288
5Y7.20410Y9.561-2.357
1.3.2. Quick Ratio

Measures if Beijing SL Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Beijing SL Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.38 means the company can pay off ¥1.38 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Beijing SL Pharmaceutical Co Ltd:

  • The MRQ is 1.376. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.376. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.376TTM1.3760.000
TTM1.376YOY1.666-0.290
TTM1.3765Y1.815-0.439
5Y1.81510Y4.247-2.432

1.4. Solvency of Beijing SL Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Beijing SL Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Beijing SL Pharmaceutical Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.07 means that Beijing SL Pharmaceutical Co Ltd assets are financed with 6.7% credit (debt) and the remaining percentage (100% - 6.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Beijing SL Pharmaceutical Co Ltd:

  • The MRQ is 0.067. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.067. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.067TTM0.0670.000
TTM0.067YOY0.075-0.008
TTM0.0675Y0.078-0.011
5Y0.07810Y0.062+0.016
1.4.2. Debt to Equity Ratio

Measures if Beijing SL Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Beijing SL Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 7.3% means that company has ¥0.07 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Beijing SL Pharmaceutical Co Ltd:

  • The MRQ is 0.073. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.073. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.073TTM0.0730.000
TTM0.073YOY0.082-0.009
TTM0.0735Y0.085-0.012
5Y0.08510Y0.066+0.019

2. Market Valuation of Beijing SL Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Beijing SL Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare Beijing SL Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 36.03 means the investor is paying ¥36.03 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Beijing SL Pharmaceutical Co Ltd:

  • The EOD is 36.728. Based on the earnings, the company is overpriced. -1
  • The MRQ is 36.027. Based on the earnings, the company is overpriced. -1
  • The TTM is 36.027. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD36.728MRQ36.027+0.701
MRQ36.027TTM36.0270.000
TTM36.027YOY26.073+9.953
TTM36.0275Y32.581+3.445
5Y32.58110Y49.155-16.574
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Beijing SL Pharmaceutical Co Ltd:

  • The EOD is 38.038. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 37.311. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 37.311. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD38.038MRQ37.311+0.726
MRQ37.311TTM37.3110.000
TTM37.311YOY48.769-11.458
TTM37.3115Y56.844-19.532
5Y56.84410Y105.233-48.389
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Beijing SL Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Beijing SL Pharmaceutical Co Ltd:

  • The EOD is 1.571. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.541. Based on the equity, the company is underpriced. +1
  • The TTM is 1.541. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.571MRQ1.541+0.030
MRQ1.541TTM1.5410.000
TTM1.541YOY2.085-0.544
TTM1.5415Y2.830-1.289
5Y2.83010Y7.091-4.260
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Beijing SL Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1490.1490%0.332-55%0.230-35%0.328-55%
Book Value Per Share--5.3335.3330%5.184+3%4.892+9%4.160+28%
Current Ratio--6.9166.9160%7.071-2%7.204-4%9.561-28%
Debt To Asset Ratio--0.0670.0670%0.075-10%0.078-14%0.062+10%
Debt To Equity Ratio--0.0730.0730%0.082-11%0.085-15%0.066+9%
Dividend Per Share--0.1000.1000%0.1000%0.187-46%0.152-34%
Eps--0.2280.2280%0.415-45%0.406-44%0.479-52%
Free Cash Flow Per Share--0.2200.2200%0.222-1%0.246-11%0.251-12%
Free Cash Flow To Equity Per Share--0.2200.2200%0.121+82%0.080+174%0.130+69%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--2.796--------
Intrinsic Value_10Y_min---0.533--------
Intrinsic Value_1Y_max--0.258--------
Intrinsic Value_1Y_min--0.137--------
Intrinsic Value_3Y_max--0.791--------
Intrinsic Value_3Y_min--0.249--------
Intrinsic Value_5Y_max--1.345--------
Intrinsic Value_5Y_min--0.182--------
Market Cap8609193134.080+2%8444817131.5208444817131.5200%11105653672.960-24%13784982514.688-39%25521470191.473-67%
Net Profit Margin--0.2230.2230%0.351-36%0.281-21%0.385-42%
Operating Margin----0%0.175-100%0.168-100%0.215-100%
Operating Ratio--0.9760.9760%0.941+4%0.953+2%0.808+21%
Pb Ratio1.571+2%1.5411.5410%2.085-26%2.830-46%7.091-78%
Pe Ratio36.728+2%36.02736.0270%26.073+38%32.581+11%49.155-27%
Price Per Share8.380+2%8.2208.2200%10.810-24%13.418-39%24.842-67%
Price To Free Cash Flow Ratio38.038+2%37.31137.3110%48.769-23%56.844-34%105.233-65%
Price To Total Gains Ratio33.663+2%33.02133.0210%24.989+32%31.614+4%49.207-33%
Quick Ratio--1.3761.3760%1.666-17%1.815-24%4.247-68%
Return On Assets--0.0400.0400%0.074-46%0.078-49%0.119-67%
Return On Equity--0.0430.0430%0.080-47%0.085-50%0.127-66%
Total Gains Per Share--0.2490.2490%0.433-42%0.416-40%0.479-48%
Usd Book Value--757230720.383757230720.3830%736084968.808+3%694591950.374+9%590705496.663+28%
Usd Book Value Change Per Share--0.0210.0210%0.046-55%0.032-35%0.045-55%
Usd Book Value Per Share--0.7370.7370%0.716+3%0.676+9%0.575+28%
Usd Dividend Per Share--0.0140.0140%0.0140%0.026-46%0.021-34%
Usd Eps--0.0320.0320%0.057-45%0.056-44%0.066-52%
Usd Free Cash Flow--31279285.59331279285.5930%31470791.342-1%34958669.597-11%35595200.247-12%
Usd Free Cash Flow Per Share--0.0300.0300%0.031-1%0.034-11%0.035-12%
Usd Free Cash Flow To Equity Per Share--0.0300.0300%0.017+82%0.011+174%0.018+69%
Usd Market Cap1189790491.130+2%1167073727.5761167073727.5760%1534801337.603-24%1905084583.530-39%3527067180.462-67%
Usd Price Per Share1.158+2%1.1361.1360%1.494-24%1.854-39%3.433-67%
Usd Profit--32394655.19532394655.1950%58864847.937-45%57582012.716-44%67945997.220-52%
Usd Revenue--145132861.919145132861.9190%167886814.533-14%209369823.677-31%184525841.175-21%
Usd Total Gains Per Share--0.0340.0340%0.060-42%0.058-40%0.066-48%
 EOD+4 -4MRQTTM+0 -0YOY+11 -245Y+11 -2410Y+9 -26

3.2. Fundamental Score

Let's check the fundamental score of Beijing SL Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1536.728
Price to Book Ratio (EOD)Between0-11.571
Net Profit Margin (MRQ)Greater than00.223
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.376
Current Ratio (MRQ)Greater than16.916
Debt to Asset Ratio (MRQ)Less than10.067
Debt to Equity Ratio (MRQ)Less than10.073
Return on Equity (MRQ)Greater than0.150.043
Return on Assets (MRQ)Greater than0.050.040
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Beijing SL Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.525
Ma 20Greater thanMa 508.785
Ma 50Greater thanMa 1008.824
Ma 100Greater thanMa 2009.605
OpenGreater thanClose8.140
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets5,875,840
Total Liabilities396,602
Total Stockholder Equity5,468,082
 As reported
Total Liabilities 396,602
Total Stockholder Equity+ 5,468,082
Total Assets = 5,875,840

Assets

Total Assets5,875,840
Total Current Assets1,997,674
Long-term Assets3,878,166
Total Current Assets
Cash And Cash Equivalents 595,038
Short-term Investments 144,906
Net Receivables 252,570
Inventory 136,818
Other Current Assets 714,505
Total Current Assets  (as reported)1,997,674
Total Current Assets  (calculated)1,843,837
+/- 153,837
Long-term Assets
Property Plant Equipment 527,304
Intangible Assets 978,507
Long-term Assets Other 875,538
Long-term Assets  (as reported)3,878,166
Long-term Assets  (calculated)2,381,348
+/- 1,496,818

Liabilities & Shareholders' Equity

Total Current Liabilities288,831
Long-term Liabilities107,770
Total Stockholder Equity5,468,082
Total Current Liabilities
Accounts payable 176,179
Other Current Liabilities 2,109
Total Current Liabilities  (as reported)288,831
Total Current Liabilities  (calculated)178,288
+/- 110,543
Long-term Liabilities
Long-term Liabilities  (as reported)107,770
Long-term Liabilities  (calculated)0
+/- 107,770
Total Stockholder Equity
Retained Earnings 3,763,808
Total Stockholder Equity (as reported)5,468,082
Total Stockholder Equity (calculated)3,763,808
+/- 1,704,274
Other
Capital Stock1,027,350
Common Stock Shares Outstanding 1,027,350
Net Invested Capital 5,468,082
Net Working Capital 1,708,843
Property Plant and Equipment Gross 930,863



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-31
> Total Assets 
77,130
102,835
151,831
389,826
405,908
461,606
586,635
788,516
1,019,806
1,248,573
1,736,141
2,216,702
2,712,099
3,319,069
3,761,619
4,081,272
4,585,062
4,988,274
5,224,966
5,394,829
5,760,464
5,875,840
5,875,8405,760,4645,394,8295,224,9664,988,2744,585,0624,081,2723,761,6193,319,0692,712,0992,216,7021,736,1411,248,5731,019,806788,516586,635461,606405,908389,826151,831102,83577,130
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,584,150
2,737,659
3,053,046
2,803,158
2,865,342
2,207,337
2,297,730
1,997,674
1,997,6742,297,7302,207,3372,865,3422,803,1583,053,0462,737,6592,584,15000000000000000
       Cash And Cash Equivalents 
3,667
11,715
31,924
237,847
195,427
205,715
261,869
420,809
418,123
445,892
572,783
660,886
762,976
856,796
1,469,562
1,171,716
1,438,805
1,166,198
1,260,864
663,480
827,837
595,038
595,038827,837663,4801,260,8641,166,1981,438,8051,171,7161,469,562856,796762,976660,886572,783445,892418,123420,809261,869205,715195,427237,84731,92411,7153,667
       Short-term Investments 
0
0
14,000
0
14,755
0
31,050
12,225
21,856
11,566
8,784
8,910
6,353
310,379
100,272
36,482
70,307
29,653
140,450
173,811
162,364
144,906
144,906162,364173,811140,45029,65370,30736,482100,272310,3796,3538,9108,78411,56621,85612,22531,050014,755014,00000
       Net Receivables 
12,726
16,698
19,406
24,656
24,815
30,776
41,665
71,066
122,921
144,084
277,196
418,989
554,751
839,236
793,472
726,559
746,935
716,023
644,491
445,862
379,162
252,570
252,570379,162445,862644,491716,023746,935726,559793,472839,236554,751418,989277,196144,084122,92171,06641,66530,77624,81524,65619,40616,69812,726
       Inventory 
1,088
3,894
9,162
7,676
8,157
7,530
6,134
8,615
24,375
29,522
64,557
57,051
110,891
112,212
129,666
198,216
275,696
251,268
108,346
112,032
124,832
136,818
136,818124,832112,032108,346251,268275,696198,216129,666112,212110,89157,05164,55729,52224,3758,6156,1347,5308,1577,6769,1623,8941,088
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,343,613
1,532,015
2,185,116
2,359,624
3,187,492
3,462,734
3,878,166
3,878,1663,462,7343,187,4922,359,6242,185,1161,532,0151,343,613000000000000000
       Property Plant Equipment 
27,763
46,222
46,790
73,249
98,591
103,550
120,337
112,872
118,364
198,411
214,334
347,885
423,269
414,145
459,754
481,067
556,315
559,344
587,959
589,155
604,012
527,304
527,304604,012589,155587,959559,344556,315481,067459,754414,145423,269347,885214,334198,411118,364112,872120,337103,55098,59173,24946,79046,22227,763
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
257,552
292,324
209,099
520,020
0
0
0
0
0000520,020209,099292,324257,55200000000000000
       Intangible Assets 
10,056
11,452
18,576
18,911
13,705
11,237
8,768
10,057
17,651
21,076
18,356
14,989
12,259
78,105
85,482
259,205
363,215
708,798
641,178
713,677
872,816
978,507
978,507872,816713,677641,178708,798363,215259,20585,48278,10512,25914,98918,35621,07617,65110,0578,76811,23713,70518,91118,57611,45210,056
       Other Assets 
0
0
1
0
2
0
4,555
11,958
52,595
130,142
152,848
174,037
215,289
318,300
374,682
464,253
540,832
588,120
775,858
923,469
975,624
0
0975,624923,469775,858588,120540,832464,253374,682318,300215,289174,037152,848130,14252,59511,9584,555020100
> Total Liabilities 
10,838
17,229
36,783
28,380
23,421
35,411
34,709
25,905
36,750
37,222
50,517
105,170
123,089
137,923
148,402
151,191
285,671
469,732
403,757
410,094
434,234
396,602
396,602434,234410,094403,757469,732285,671151,191148,402137,923123,089105,17050,51737,22236,75025,90534,70935,41123,42128,38036,78317,22910,838
   > Total Current Liabilities 
7,188
11,649
32,383
22,280
17,291
26,051
32,211
25,905
32,209
37,222
45,217
92,220
103,521
115,736
111,000
113,666
249,667
437,227
332,634
314,975
324,958
288,831
288,831324,958314,975332,634437,227249,667113,666111,000115,736103,52192,22045,21737,22232,20925,90532,21126,05117,29122,28032,38311,6497,188
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,936
5,510
0
0
005,5103,936000000000000000000
       Accounts payable 
233
5,145
4,443
19,305
8,378
14,433
14,563
11,560
11,760
8,051
9,600
27,056
36,462
42,669
39,827
30,914
111,501
264,946
178,506
179,927
191,400
176,179
176,179191,400179,927178,506264,946111,50130,91439,82742,66936,46227,0569,6008,05111,76011,56014,56314,4338,37819,3054,4435,145233
       Other Current Liabilities 
5,455
6,504
8,730
2,975
8,913
11,618
17,648
14,345
20,449
29,171
35,617
65,164
67,059
71,293
41,681
48,803
99,963
126,749
120,473
104,304
101,513
2,109
2,109101,513104,304120,473126,74999,96348,80341,68171,29367,05965,16435,61729,17120,44914,34517,64811,6188,9132,9758,7306,5045,455
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
37,526
36,004
29,207
71,123
95,118
109,276
107,770
107,770109,27695,11871,12329,20736,00437,526000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,222
0
02,22200000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
133,259
153,237
137,552
191,216
233,749
291,838
394,723
0
0394,723291,838233,749191,216137,552153,237133,25900000000000000
> Total Stockholder Equity
66,292
85,607
114,950
361,357
381,876
425,565
551,272
760,409
965,513
1,190,752
1,623,979
2,040,118
2,565,664
3,147,944
3,577,848
3,896,513
4,270,639
4,497,847
4,808,197
4,974,607
5,311,498
5,468,082
5,468,0825,311,4984,974,6074,808,1974,497,8474,270,6393,896,5133,577,8483,147,9442,565,6642,040,1181,623,9791,190,752965,513760,409551,272425,565381,876361,357114,95085,60766,292
   Common Stock
40,000
40,000
50,000
69,000
82,800
82,800
124,200
248,400
251,400
252,980
380,700
380,700
456,840
456,840
684,900
684,900
684,900
684,900
1,027,350
1,027,350
1,027,350
0
01,027,3501,027,3501,027,350684,900684,900684,900684,900456,840456,840380,700380,700252,980251,400248,400124,20082,80082,80069,00050,00040,00040,000
   Retained Earnings 
21,309
37,709
50,235
77,452
92,399
129,442
236,357
426,003
602,144
803,972
1,118,534
1,478,777
1,826,645
2,677,120
2,877,661
3,192,789
3,589,384
3,818,384
3,782,107
3,941,345
4,264,550
3,763,808
3,763,8084,264,5503,941,3453,782,1073,818,3843,589,3843,192,7892,877,6612,677,1201,826,6451,478,7771,118,534803,972602,144426,003236,357129,44292,39977,45250,23537,70921,309
   Capital Surplus 0000000000000000000000
   Treasury Stock00000000-9,4680000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,892
11,350
-11,118
-12,910
-8,734
-11,678
-12,986
0
0-12,986-11,678-8,734-12,910-11,11811,3507,89200000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue999,824
Cost of Revenue-177,508
Gross Profit822,316822,316
 
Operating Income (+$)
Gross Profit822,316
Operating Expense-786,980
Operating Income212,84435,336
 
Operating Expense (+$)
Research Development165,847
Selling General Administrative344,508
Selling And Marketing Expenses-
Operating Expense786,980510,354
 
Net Interest Income (+$)
Interest Income22,420
Interest Expense--
Other Finance Cost-12,395
Net Interest Income10,025
 
Pretax Income (+$)
Operating Income212,844
Net Interest Income10,025
Other Non-Operating Income Expenses-
Income Before Tax (EBT)354,073212,844
EBIT - interestExpense = 0
314,024
314,024
Interest Expense-
Earnings Before Interest and Taxes (EBIT)-354,073
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax354,073
Tax Provision-44,364
Net Income From Continuing Ops309,709309,709
Net Income314,024
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--10,025
 

Technical Analysis of Beijing SL Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Beijing SL Pharmaceutical Co Ltd. The general trend of Beijing SL Pharmaceutical Co Ltd is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Beijing SL Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Beijing SL Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 8.53 < 9.7 < 9.73.

The bearish price targets are: 7.05.

Tweet this
Beijing SL Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Beijing SL Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Beijing SL Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Beijing SL Pharmaceutical Co Ltd. The current macd is -0.19912628.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Beijing SL Pharmaceutical Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Beijing SL Pharmaceutical Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Beijing SL Pharmaceutical Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Beijing SL Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartBeijing SL Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Beijing SL Pharmaceutical Co Ltd. The current adx is 18.57.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Beijing SL Pharmaceutical Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Beijing SL Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Beijing SL Pharmaceutical Co Ltd. The current sar is 8.77070111.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Beijing SL Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Beijing SL Pharmaceutical Co Ltd. The current rsi is 40.52. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Beijing SL Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartBeijing SL Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Beijing SL Pharmaceutical Co Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Beijing SL Pharmaceutical Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Beijing SL Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartBeijing SL Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Beijing SL Pharmaceutical Co Ltd. The current cci is -123.80891747.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Beijing SL Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartBeijing SL Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Beijing SL Pharmaceutical Co Ltd. The current cmo is -20.93253842.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Beijing SL Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartBeijing SL Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Beijing SL Pharmaceutical Co Ltd. The current willr is -69.07216495.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Beijing SL Pharmaceutical Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Beijing SL Pharmaceutical Co Ltd Daily Williams %R ChartBeijing SL Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Beijing SL Pharmaceutical Co Ltd.

Beijing SL Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Beijing SL Pharmaceutical Co Ltd. The current atr is 0.28213055.

Beijing SL Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartBeijing SL Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Beijing SL Pharmaceutical Co Ltd. The current obv is 1,234,221,519.

Beijing SL Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartBeijing SL Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Beijing SL Pharmaceutical Co Ltd. The current mfi is 40.93.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Beijing SL Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartBeijing SL Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Beijing SL Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-11-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-23STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-11-24STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-25MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Beijing SL Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Beijing SL Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.525
Ma 20Greater thanMa 508.785
Ma 50Greater thanMa 1008.824
Ma 100Greater thanMa 2009.605
OpenGreater thanClose8.140
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Beijing SL Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Beijing SL Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Beijing SL Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Beijing SL Pharmaceutical Co Ltd

I send you an email if I find something interesting about Beijing SL Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Beijing SL Pharmaceutical Co Ltd.

Receive notifications about Beijing SL Pharmaceutical Co Ltd in your mailbox!